Insider Cluster (3 insiders) ·Filed Mar 5, 2026

XNCR

Xencor Inc
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $196K total
Actionable Insight • Neutral

Monitor for any pattern of increasing insider selling in coming weeks; currently, this level of activity is within normal range for executives managing personal holdings.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
XNCR ▲ +5.73% at T+60d
NEUTRAL call ✓ call won +5.73% · α vs SPY -5.57% · entry $11.16 → $11.80
Entry anchored
Mar 4, 03:59 PM ET
via exchange tick
T+1d
+1.43%
call +1.43% · α +2.75%
$11.32
settled 7mo ago
T+5d
+4.03%
call +4.03% · α +6.27%
$11.61
settled 7mo ago
T+20d
+14.78%
call +14.78% · α +18.57%
$12.81
settled 6mo ago
T+60d
+5.73%
call +5.73% · α -5.57%
$11.80
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Five open-market share sales by three Xencor executives—CEO, CFO, and General Counsel—over two days, totaling $324,274. The transactions are small relative to the company's $830M market cap, representing just 0.04% of equity value, and appear routine.

Key Financial Metrics

Direction
selling
Total Value
$324.3K
Insiders
3

Key Facts

  • CEO Dahiyat Bassil sold 21,476 shares for $240,017 across two trades on March 5 and 6.
  • CFO Bart Jan Cornelissen sold 2,517 shares for $28,305 on March 5.
  • General Counsel Celia Eckert sold 5,011 shares for $55,952 across two trades.
  • All transactions were open-market sales (Form 4 code 'S') with no non-cash or derivative-related activity.
  • Total insider selling cluster value: $324,274 over 7 days, or 0.04% of $830M market cap.

Financial Impact

$324,274 in total open-market sales by insiders

insider ownershipshares outstanding

Risk Factors

  • Perception risk if selling continues or accelerates ahead of next earnings or clinical catalysts.
  • Concentration of sales among top executives (CEO, CFO, GC) may raise questions, though dollar amounts are small.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (5 trades, 7d window)cluster-XNCR-1773086823812
10 reports for XNCR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +67.24%May 5, 2026
Filters
Rows
Reports for XNCR — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$20.00 $26.62▲ +33.10%▲ +32.50%$24.32 (+21.60%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$12.64 $14.95▲ +18.28%▲ +17.74%$24.32 (+92.41%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$12.21 $14.96▲ +22.52%▲ +23.27%$24.32 (+99.18%)
Jun 15, 2026
15w ago
144
NEUTRAL ★ 2/10
$12.21 $14.96▲ +22.52%▲ +23.27%$24.32 (+99.18%)
May 6, 2026
21w ago
8-K
BEARISH ★ 7/10
$12.31 $11.42▲ +7.23%▲ +10.37%$24.32 (−97.56%)
May 5, 2026
21w ago
8-K
BULLISH ★ 7/10
$12.85 $11.21▼ −12.76%▼ −17.72%$24.32 (+89.26%)
Apr 27, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$12.15 $11.63▼ −4.28%▼ −9.75%$24.32 (+100.16%)
Mar 5, 2026
30w ago
Insider Cluster
NEUTRAL ★ 3/10
$11.16 $12.81▲ +14.78%▲ +18.57%$24.32 (+117.92%)
Mar 4, 2026
30w ago
8-K
BEARISH ★ 8/10
$11.16 $12.81▼ −14.78%▼ −18.57%$24.32 (−117.92%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 7/10
$11.98 $12.40▲ +3.51%▲ +8.74%$24.32 (+103.01%)
Showing 10 of 10

US Market Status

Market Open — Closes in 1h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 9, 2026